BRAIN Biotech AG (LON:0RFI)

BRAIN Biotech AG Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	17.82	27.17	5.35	8.44	24.55	18.94
Short-Term Investments	-	0.06	0.06	0.08	0.06	0.05
Cash & Short-Term Investments	17.82	27.23	5.41	8.53	24.6	19
Cash Growth	291.33%	403.59%	-36.58%	-65.35%	29.50%	24.79%
Accounts Receivable	-	7.8	9.44	8.04	6.72	6.17
Other Receivables	-	0.32	0.27	3.24	0.13	0.17
Receivables	-	8.24	9.83	11.35	6.95	6.57
Inventory	-	9.42	9.76	9.66	7.02	6.96
Prepaid Expenses	-	0.6	0.39	0.33	0.32	0.28
Other Current Assets	19.28	0.17	0.09	0.52	0.23	0.28
Total Current Assets	37.11	45.66	25.48	30.38	39.11	33.08
Property, Plant & Equipment	-	27.86	28.72	28.74	24.29	24.47
Long-Term Investments	-	0.97	1.46	1.94	0.55	1
Goodwill	-	6.81	6.67	6.61	4.73	4.48
Other Intangible Assets	-	7.38	8.55	10.16	8.81	8.79
Long-Term Deferred Charges	-	0.07	0.02	0.06	-	0.11
Other Long-Term Assets	43.22	0	-	0.01	0.1	0.02
Total Assets	80.33	88.74	70.94	77.99	77.74	72.15
Accounts Payable	-	5.61	5.62	6.75	3.83	3.17
Accrued Expenses	-	5.91	3.6	2.67	2.28	3.45
Current Portion of Long-Term Debt	-	7.41	2.26	1.43	1.24	1.25
Current Portion of Leases	-	1.57	1.44	1.27	1.08	1.08
Current Income Taxes Payable	-	-	0.04	0.17	0.06	0.19
Current Unearned Revenue	-	0.62	2.93	1.99	1.57	0.86
Other Current Liabilities	19.8	3.89	1.59	7.1	1.27	2.35
Total Current Liabilities	19.8	25.01	17.48	21.39	11.34	12.36
Long-Term Debt	-	10.71	-	2.62	3.48	4.22
Long-Term Leases	-	6.62	6.74	5.41	5.58	6.53
Long-Term Unearned Revenue	-	1.12	0.52	0.77	1.11	1.37
Long-Term Deferred Tax Liabilities	-	3.88	3.77	3.29	2.79	2.16
Other Long-Term Liabilities	50.22	26.59	18.49	9.11	9.35	16.57
Total Liabilities	70.02	74.85	47.92	43.74	35.91	46.01
Common Stock	10.31	21.85	21.85	21.85	21.85	19.86
Additional Paid-In Capital	-	94.95	93.46	92.66	95.89	78.39
Retained Earnings	-	-105.49	-94.16	-85.2	-79.51	-77.5
Comprehensive Income & Other	-	1.31	0.63	0.33	0.56	0.04
Total Common Equity	10.31	12.62	21.77	29.64	38.78	20.79
Minority Interest	-	1.27	1.24	4.61	3.04	5.36
Shareholders' Equity	10.31	13.89	23.01	34.25	41.83	26.14
Total Liabilities & Equity	80.33	88.74	70.94	77.99	77.74	72.15
Total Debt	-	26.3	10.44	10.74	11.38	13.09
Net Cash (Debt)	17.82	0.93	-5.03	-2.21	13.22	5.91
Net Cash Growth	291.33%	-	-	-	123.82%	-25.05%
Net Cash Per Share	0.82	0.04	-0.23	-0.10	0.66	0.32
Filing Date Shares Outstanding	21.85	21.85	21.85	21.85	21.85	18.06
Total Common Shares Outstanding	21.85	21.85	21.85	21.85	21.85	18.06
Working Capital	17.31	20.65	8	9	27.78	20.73
Book Value Per Share	0.47	0.58	1.00	1.36	1.78	1.15
Tangible Book Value	10.31	-1.57	6.56	12.87	25.25	7.51
Tangible Book Value Per Share	0.47	-0.07	0.30	0.59	1.16	0.42
Land	-	10.66	10.42	10.33	16.26	16.03
Machinery	-	22.38	21.55	22.68	20.59	18.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.